Jane Street Group, LLC Akebia Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	BUY	$0.72 - $2.93 $92,736 - $377,384	128,800 Added 445.67%	157,700 $113,000
Q4 2021 Feb 15, 2022	SELL	$2.26 - $3.34 $18,984 - $28,056	-8,400 Reduced 22.52%	28,900 $65,000
Q3 2021 Nov 16, 2021	BUY	$2.35 - $3.88 $705 - $1,164	300 Added 0.81%	37,300 $107,000
Q2 2021 Aug 16, 2021	BUY	$2.83 - $4.2 $63,109 - $93,660	22,300 Added 151.7%	37,000 $140,000
Q1 2021 May 18, 2021	SELL	$2.92 - $5.06 $27,448 - $47,563	-9,400 Reduced 39.0%	14,700 $50,000
Q4 2020 Feb 17, 2021	BUY	$2.22 - $3.78 $53,502 - $91,098	24,100 New	24,100 $67,000

121

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $329M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.